Search

everythinglearnresearchcommunity

for

Search:↓

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Certain genes control the color of human hair by affecting pigment production.

EVAL membranes help create cell structures that can regrow hair follicles.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Muscles and nerves that cause goosebumps also help control hair growth.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

HFMs can help study hair growth and test potential hair growth drugs.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Advanced human skin models improve drug development and could replace animal testing.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

PRP treatment may stimulate hair growth by promoting blood vessel formation, increasing growth factors, and preventing cell death.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Activating Nrf2 protects human hair follicles from oxidative stress and helps prevent hair growth inhibition.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Some drugs may reduce prostatitis symptoms short-term with few side effects.